Format

Send to

Choose Destination
Oncotarget. 2015 Nov 24;6(37):39714-24. doi: 10.18632/oncotarget.5356.

Suppressing NRIP1 inhibits growth of breast cancer cells in vitro and in vivo.

Author information

1
Division of Geriatrics, Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois 62794-9628, USA.
2
Department of Medical Microbiology and Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, Illinois 62794-9628, USA.
3
Zhongda Hospital, Southeast University of China, Nanjing 210009, China.
4
Department of Pathology, Southern Illinois University School of Medicine, Springfield, Illinois 62794-9628, USA.
5
Department of Oncology, Nanjing Junxie Hospital, Nanjing 210002, China.

Abstract

Earlier age at menarche is a major risk factor for breast cancer. Our previous study identified Nrip1 (also known as Rip140) as a candidate gene for delaying female sexual maturation (FSM) and found that knocking out Nrip1 could significantly delay FSM in mice. To investigate the effects of NRIP1 in breast cancer we used human cell lines and tissue arrays along with an in vivo study of DMBA-induced carcinogenesis in Nrip1 knockout mice. Analysis of tissue arrays found that NRIP1 is elevated in tumors compared to cancer adjacent normal tissue. Interestingly, in benign tumors NRIP1 levels are higher in the cytosol of stromal cells, but NRIP1 levels are higher in the nuclei of epithelial cells in malignancies. We also found overexpression of NRIP1 in breast cancer cell lines, and that suppression of NRIP1 by siRNA in these cells significantly induced apoptosis and inhibited cell growth. Furthermore, in vivo data suggests that NRIP1 is upregulated in DMBA-induced breast cancer. Importantly, we found that DMBA-induced carcinogenesis is suppressed in Nrip1 knockdown mice. These findings suggest that NRIP1 plays a critical role in promoting the progression and development of breast cancer and that it may be a potential therapeutic target for the new breast cancer treatments.

KEYWORDS:

NRIP1; apoptosis; breast cancer; cell survival; human tissue array

PMID:
26492163
PMCID:
PMC4741857
DOI:
10.18632/oncotarget.5356
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center